3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
2
Not yet recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Plasma cell
1
Conditions
Paraproteinemias
1
Multiple Myeloma
1
Monoclonal Gammopathy of Undetermined Significance
1
Immunoglobulin Light-chain Amyloidosis
1
Interventions
Standard of Care
26
Exercise
24
Interviews as Topic
19
Blood Specimen Collection
18
Educational Status
13
Methods
12
Surgical Procedures, Operative
11
Drug Therapy
11
Radiosurgery
10
Surveys and Questionnaires
9
Specimen Handling
9
Saline Solution
9
Acupuncture Therapy
9
Paclitaxel
8
Early Intervention, Educational
8
Therapeutics
7
Radiotherapy
7
Practice Guidelines as Topic
7
Magnetic Resonance Spectroscopy
7
Electroacupuncture
7
Cryotherapy
7
Resistance Training
6
Preoperative Exercise
6
Palliative Care
6
Dexmedetomidine
6
Control Groups
6
Colonoscopy
6
Carboplatin
6
tislelizumab
5
Sentinel Lymph Node Biopsy
5
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase NA
×
Not yet recruiting
×
4-(N-methylamino)-4'-(2-(2-(2-fluoroethoxy)ethoxy)ethoxy)stilbene
×
Clear all
NCT07624760
2026-06-03
MGUS-PET
University of Zurich
Phase NA
Not yet recruiting
50 enrolled